You are here

Article Text

Article menu
Download PDFPDF
Editorial
Choosing the right empirical antibiotics for neonates

https://doi.org/10.1136/adc.2010.188938

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Funding NIH.

    • Competing interests PBS received support from NICHD 1K23HD060040-01 and from industry for neonatal and paediatric drug development (www.dcri.duke.edu/research/coi.jsp). DKB receives support from the US Government for his work in paediatric and neonatal clinical pharmacology (1R01HD057956-02, 1R01FD003519-01, 1U10-HD45962-06, 1K24HD058735-01, HHSN267200700051C), the non-profit organisation Thrasher Research Foundation for his work in neonatal candidiasis (http://www.thrasherresearch.org), and from industry for neonatal and paediatric drug development (www.dcri.duke.edu/research/coi.jsp).

    • Provenance and peer review Commissioned; internally peer reviewed.